Mobile Site ›

Test ID: TAKRO    
Tacrolimus, Blood

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Useful For Suggests clinical disorders or settings where the test may be helpful

Monitoring whole blood tacrolimus concentration during therapy, particularly in individuals coadministered CYP3A4 substrates, inhibitors, or inducers


Adjusting dose to optimize immunosuppression while minimizing toxicity


Evaluating patient compliance

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Tacrolimus, B

Aliases Lists additional common names for a test, as an aid in searching